There is no consensus on the best method of managing ABO-incompatible BMT. 18 The most commonly used strategy is red cell depletion. Herein, we report on the safety of recipient plasma exchange ...
In an analysis of the long-term outcome of 85 adults and children with acute myeloid leukemia (AML) who underwent allogeneic BMT in the first complete remission (CR) after cyclophosphamide and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback